Inventor · disambiguated record
Marc Nolte
Also filed as: NOLTE MARC
14 granted patents·6 pending applications·53 citations·filing 2009–2024
90Inventor score
Top patents by PatentIndex Score
20 records- 0190US9856326B2Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodiesCSL BEHRING GMBH·Filed 2016·Granted Jan 2, 2018·9 cites·23 claims
- 0288US9856325B2Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodiesCSL BEHRING GMBH·Filed 2016·Granted Jan 2, 2018·6 cites·24 claims
- 0385US9518127B2Inhibitory anti-factor XII/XIIA monoclonal antibodies and their usesPANOUSIS CON·Filed 2012·Granted Dec 13, 2016·8 cites·22 claims
- 0483US10286047B2Treatment and prevention of remote ischemia-reperfusion injuryUNIV BERN·Filed 2014·Granted May 14, 2019·11 cites·10 claims
- 0582US9987328B2Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfacesCSL BEHRING GMBH·Filed 2016·Granted Jun 5, 2018·4 cites·20 claims
- 0676US10513560B2Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodiesCSL BEHRING GMBH·Filed 2017·Granted Dec 24, 2019·1 cites·21 claims
- 0776US2024398914A1Combination therapy using a factor xii inhibitor and a c-1 inhibitorCSL BEHRING GMBH·Filed 2024·Application pending·0 cites
- 0874US9352016B2Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfacesZEITLER STEFAN·Filed 2012·Granted May 31, 2016·5 cites·17 claims
- 0972US9624307B2Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organsNAHRENDORF MATTHIAS·Filed 2012·Granted Apr 18, 2017·5 cites·13 claims
- 1069US9957329B2Factor XII inhibitors for the treatment of neurological inflammatory disordersCSL BEHRING GMBH·Filed 2013·Granted May 1, 2018·3 cites·14 claims
- 1167US11345759B2Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodiesCSL BEHRING GMBH·Filed 2019·Granted May 31, 2022·0 cites·22 claims
- 1267US2020129600A1Combination therapy using a factor xii inhibitor and a c-1 inhibitorCSL BEHRING GMBH·Filed 2019·Application pending·0 cites
- 1365US9452203B2Use of C1-inhibitor for the treatment of secondary edema of the central nervous systemCSL BEHRING GMBH·Filed 2012·Granted Sep 27, 2016·1 cites·30 claims
- 1454US10973891B2Treatment and prevention of remote ischemia-reperfusion injuryCSL BEHRING GMBH·Filed 2019·Granted Apr 13, 2021·0 cites·21 claims
- 1554US2016166660A1Combination therapy using a factor xii inhibitor and a c-1 inhibitorCSL BEHRING GMBH·Filed 2014·Application pending·0 cites
- 1650US12065481B2Therapy using a factor XII inhibitor in a neurotraumatic disorderCSL BEHRING GMBH·Filed 2019·Granted Aug 20, 2024·0 cites·18 claims
- 1744US2012196873A1Stabilization of amorphous drugs using sponge-like carrier matricesNOLTE MARC·Filed 2009·Application pending·0 cites
- 1839US11505619B2Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney diseaseCSL LTD·Filed 2018·Granted Nov 22, 2022·0 cites·17 claims
- 1939US2020093901A1Subcutaneous administration of long-acting factor ix in humansCSL Behring Lengnau AG·Filed 2017·Application pending·0 cites
- 2029US2017114119A1Therapy using a factor xii inhibitor in a neurotraumatic disorderCSL BEHRING GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Nolte files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →